CTOs on the Move

Symmetry Surgical

www.symmetrysurgical.com

 
Symmetry Surgical is dedicated to developing high-quality surgical instruments that respond to clinicians` needs as they arise, making a real difference in the lives of patients.   Our broad portfolio also brings together the rich history and distinctive product lines of the recently acquired stainless steel and titanium surgical instruments of Codman, the surgical instruments of Specialty Surgical Instrumentation (SSI) and the electrosurgery instruments of Olsen Medical.   Offering one of the most comprehensive suites of surgical instruments in the industry, we continue to collaborate with clinicians, global medical device manufacturers and thousands of hospitals to provide solutions for today`s needs and tomorrow`s growth.   Headquartered ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Coltene/Whaledent

Coltene/Whaledent is a Cuyahoga Falls, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oraya Therapeutics

Oraya Therapeutics is a privately held, development-stage medical technology company, pioneering noninvasive radiation treatments for inflammatory and neovascular diseases of the eye. The company is currently testing its first application of the IRay stereotactic radiotherapy system.

Forzzi Optical

Forzzi Optical L.C. is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Emboline, Inc.

Emboline is a medical device company with a game-changing device for total embolic protection during percutaneous heart valve repair and replacement procedures and other cardiovascular procedures with embolic risks.

Valeritas

Valeritas is committed to developing and commercializing innovative treatment solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of Type 2 diabetes. Valeritas` portfolio is headlined by the V-Go® disposable insulin delivery device, which is being commercialized and reimbursed in a specialty pharmaceutical model and is distributed through retail pharmacy.